Literature DB >> 17404233

CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine.

Meike Wendland1, Niklas Czeloth, Nicolas Mach, Bernard Malissen, Elisabeth Kremmer, Oliver Pabst, Reinhold Förster.   

Abstract

Small intestine plasmacytoid dendritic cells (pDC) are poorly characterized. Here, we demonstrate that intestinal pDC show the characteristic plasma cell-like morphology, and are recognized by antibodies against B220, Ly6c, 120G8, and PDCA-1, markers that are typically expressed by pDC. Furthermore, intestinal pDC carry high levels of CCR9 and are largely absent in the intestine, but not in lung, liver, or secondary lymphoid organs of CCR9-deficient animals. Competitive adoptive transfers reveal that CCR9-deficient pDC are impaired in homing to the small intestine after i.v. transfer. In a model of cholera toxin-induced gut inflammation, pDC are recruited to the intestine in WT but not CCR9-deficient animals. Furthermore, after oral application of a Toll-like receptor (TLR) 7/8 ligand, myeloid DC of the lamina propria are rapidly mobilized in WT but not in CCR9-deficient animals. Mobilization of myeloid DC can be completely rescued by adoptively transferred WT pDC to CCR9-deficient mice before oral challenge. Together, our data reveal an essential role for CCR9 in the homing of pDC to the intestine under homeostatic and inflammatory conditions and demonstrate an important role for intestinal pDC for the rapid mobilization of lamina propria DC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404233      PMCID: PMC1851094          DOI: 10.1073/pnas.0609180104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand.

Authors:  Ulf Yrlid; Simon W F Milling; Joanna L Miller; Sian Cartland; Christopher D Jenkins; G Gordon MacPherson
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

3.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

4.  Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.

Authors:  M A Wurbel; M Malissen; D Guy-Grand; E Meffre; M C Nussenzweig; M Richelme; A Carrier; B Malissen
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

5.  Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody.

Authors:  Carine Asselin-Paturel; Géraldine Brizard; Jean-Jacques Pin; Francine Brière; Giorgio Trinchieri
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

6.  CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa.

Authors:  Marcus Svensson; Jan Marsal; Anna Ericsson; Laura Carramolino; Therese Brodén; Gabriel Márquez; William W Agace
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

7.  Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis.

Authors:  B A Zabel; W W Agace; J J Campbell; H M Heath; D Parent; A I Roberts; E C Ebert; N Kassam; S Qin; M Zovko; G J LaRosa; L L Yang; D Soler; E C Butcher; P D Ponath; C M Parker; D P Andrew
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

8.  Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

Authors:  E J Kunkel; J J Campbell; G Haraldsen; J Pan; J Boisvert; A I Roberts; E C Ebert; M A Vierra; S B Goodman; M C Genovese; A J Wardlaw; H B Greenberg; C M Parker; E C Butcher; D P Andrew; W W Agace
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

9.  The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor.

Authors:  Michel Gilliet; Andre Boonstra; Carine Paturel; Svetlana Antonenko; Xiu-Ling Xu; Giorgio Trinchieri; Anne O'Garra; Yong-Jun Liu
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

10.  CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.

Authors:  H Nakano; M Yanagita; M D Gunn
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  99 in total

1.  CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues.

Authors:  Vanja Sisirak; Nelly Vey; Béatrice Vanbervliet; Thomas Duhen; Isabelle Puisieux; Bernhard Homey; Edward P Bowman; Giorgio Trinchieri; Bertrand Dubois; Dominique Kaiserlian; Sergio A Lira; Alain Puisieux; Jean-Yves Blay; Christophe Caux; Nathalie Bendriss-Vermare
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

Review 2.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

Review 3.  Mononuclear phagocyte diversity in the intestine.

Authors:  Milena Bogunovic; Arthur Mortha; Paul Andrew Muller; Miriam Merad
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

4.  Inverse relationship between dendritic cell CCR9 expression and maturation state.

Authors:  Maureen L Drakes; Patrick J Stiff; Thomas G Blanchard
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

5.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

6.  Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.

Authors:  Heather W Stout-Delgado; Xin Yang; Wendy E Walker; Bethany M Tesar; Daniel R Goldstein
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 7.  Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?

Authors:  N M Rogers; J S Isenberg; A W Thomson
Journal:  Am J Transplant       Date:  2013-04-25       Impact factor: 8.086

8.  Thymus-homing dendritic cells in central tolerance.

Authors:  Husein Hadeiba; Eugene C Butcher
Journal:  Eur J Immunol       Date:  2013-05-18       Impact factor: 5.532

9.  A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections.

Authors:  Gennady Bocharov; Roland Züst; Luisa Cervantes-Barragan; Tatyana Luzyanina; Egor Chiglintsev; Valery A Chereshnev; Volker Thiel; Burkhard Ludewig
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

10.  IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function.

Authors:  Ivan Monteleone; Andrew M Platt; Elin Jaensson; William W Agace; Allan McI Mowat
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.